BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2412854)

  • 1. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
    Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
    Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for substance P. III. Classification by competitive antagonists.
    Regoli D; Escher E; Drapeau G; D'Orléans-Juste P; Mizrahi J
    Eur J Pharmacol; 1984 Jan; 97(3-4):179-89. PubMed ID: 6200337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for substance P. II. Classification by agonist fragments and homologues.
    Regoli D; Mizrahi J; D'Orléans-Juste P; Escher E
    Eur J Pharmacol; 1984 Jan; 97(3-4):171-7. PubMed ID: 6200336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea.
    Mizrahi J; Escher E; D'Orléans-Juste P; Regoli D
    Eur J Pharmacol; 1984 Mar; 99(2-3):193-202. PubMed ID: 6203766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
    Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
    Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the tachykinin antagonist, [D-Pro4, D-Trp7,9,10] substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle.
    Bailey SJ; Lippe IT; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):296-300. PubMed ID: 2438561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
    Mathison R; Solomos D
    Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P antagonists showing some selectivity for different receptor types.
    Regoli D; Mizrahi J; D'Orléans-Juste P; Dion S; Drapeau G; Escher E
    Eur J Pharmacol; 1985 Feb; 109(1):121-5. PubMed ID: 2581793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachykinin antagonist I: Specific, competitive and tissue-selective neurokinin B antagonists on contractile activity in smooth muscles.
    Hashimoto T; Uchida Y; Naminohira S; Sakai T
    Jpn J Pharmacol; 1987 Dec; 45(4):570-3. PubMed ID: 3481842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P--structure-activity studies and the development of antagonists.
    Regoli D; Escher E; Mizrahi J
    Pharmacology; 1984; 28(6):301-20. PubMed ID: 6203130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activities of substance P antagonists.
    Caranikas S; Mizrahi J; Escher E; Regoli D
    J Med Chem; 1982 Nov; 25(11):1313-6. PubMed ID: 6183430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for neurokinin-3 receptor-mediated tachykinin release in the guinea-pig ileum.
    Guard S; Watson SP
    Eur J Pharmacol; 1987 Dec; 144(3):409-12. PubMed ID: 2450037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
    Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
    Munekata E; Kubo K; Tanaka H; Osakada F
    Peptides; 1987; 8(1):169-73. PubMed ID: 2437548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist discrimination between subtypes of tachykinin receptors in the guinea-pig ileum.
    Kilbinger H; Stauss P; Erlhof I; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):181-7. PubMed ID: 2431326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.